Cargando…
Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis
Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage in the aging population. We aimed to investigate the predictive factors for atorvastatin efficacy as a monotherapy for moderate CSDH. We retrospectively reviewed the medical records of patients who were diagnosed with moder...
Autores principales: | Zhang, Xinjie, Wang, Dong, Tian, Ye, Wei, Huijie, Liu, Xuanhui, Xiang, Tangtang, Fan, Yibing, Gao, Chuang, Huang, Jinhao, Sha, Zhuang, Quan, Wei, Zhang, Jianning, Jiang, Rongcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440973/ https://www.ncbi.nlm.nih.gov/pubmed/34539386 http://dx.doi.org/10.3389/fnagi.2021.726592 |
Ejemplares similares
-
Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma
por: Wang, Dong, et al.
Publicado: (2021) -
Possible mechanism and Atorvastatin-based treatment in cupping therapy-related subdural hematoma: A case report and literature review
por: Xiang, Tangtang, et al.
Publicado: (2022) -
Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p
por: Gao, Chuang, et al.
Publicado: (2019) -
The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients
por: Fan, Yibing, et al.
Publicado: (2022) -
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases
por: Yuan, Jiangyuan, et al.
Publicado: (2021)